Sterling Biotech reports net loss of Rs 105.99 crore in the December 2013 quarter

Sales decline 25.94% to Rs 150.75 crore

Net Loss of Sterling Biotech reported to Rs 105.99 crore in the quarter ended December 2013 as against net loss of Rs 91.06 crore during the previous quarter ended December 2012. Sales declined 25.94% to Rs 150.75 crore in the quarter ended December 2013 as against Rs 203.55 crore during the previous quarter ended December 2012.

For the full year,net loss reported to Rs 400.65 crore in the year ended December 2013 as against net loss of Rs 349.77 crore during the previous year ended December 2012. Sales declined 13.98% to Rs 718.07 crore in the year ended December 2013 as against Rs 834.77 crore during the previous year ended December 2012.

ParticularsQuarter EndedYear EndedDec. 2013Dec. 2012% Var.Dec. 2013Dec. 2012% Var.Sales150.75203.55 -26 718.07834.77 -14 OPM %15.1817.72 -13.7818.52 - PBDT-92.45-66.93 -38 -338.76-257.70 -31 PBT-156.89-134.79 -16 -593.08-517.75 -15 NP-105.99-91.06 -16 -400.65-349.77 -15

Powered by Capital Market - Live News